Bupropion Hydrochloride Tablet, Film Coated
Product Images NDC 82804-127

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 82804-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-123-30 (100 mg 100 Tablets)

This is a pharmaceutical label for Bupropion HCI 100mg tablets packaged by Proficient RxLP in Thousand Oaks, CA. The tablets are purple, round, unscored, film-coated, and imprinted with "APO" on one side and "BUP" over "100" on the other side. It is important to dispense a medication guide to each patient. The warning states not to use the tablets in combination with Zyban or any other medicines containing bupropion hydrochloride. The product is manufactured by Apotex Inc. in Toronto, Ontario, Canada, and should be stored at 20°-25°C (68°-77°F). The label also includes lot numbers and expiration dates.*

FDA Label Image

82804-127-30 (75 mg 100 Tablets)

This is a medication packaging label for Bupropion HCI 75mg tablets, with instructions for dispensing and usage. The tablets are orange, round, and film-coated, with specific imprints. The label includes details such as the manufacturer (Apotex Inc.), lot number, expiration date, and storage instructions. It also contains a warning not to use the medication with other products containing bupropion hydrochloride. The label advises to dispense a medication guide with each patient's prescription.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.